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INFORMATION FOR AUTHORS
SCOPE OF THE JOURNAL
The Journal of Vascular Surgery® is dedicated to
the science and art of vascular surgery and aims to
improve the management of patients with vascular
diseases by publishing relevant papers that report
important medical advances, test new hypotheses,
and address current controversies. To achieve this
goal, the Journal will publish original clinical and
laboratory studies, and reports and papers that com-
ment on the social, economic, ethical, legal, and
political factors that relate to these aims.
As the official publication of the Society for Vas-
cular Surgery®, the Journal will publish, after careful
peer review, selected papers presented at the annual
meeting of that organization and affiliated vascular
societies, as well as original articles from members
and nonmembers.
EDITORIAL POLICIES
The editorial policies of the Journal are published
in the January and July issues, on the Internet Web
site (www.jvascsurg.org), on the Editorial Manager
Web site (http://jvs.editorialmanager.com), and are
available from the Editors on request.
ADMINISTRATIVE POLICIES
Ownership of manuscript. Manuscripts that are
accepted for publication become the property of the
Journal of Vascular Surgery®, which is copyrighted by
the Society for Vascular Surgery®. They may not be
published or reproduced inwhole or in part without the
written permission of the author(s) and the Journal.
Permission to reproduce published material.
Permission to reproduce material published in the
Journal of Vascular Surgery® must be obtained from
the publisher at (215) 239-3804 or by e-mail at
healthpermissions@elsevier.com. Authors will be
consulted, when possible, regarding reproduction or
republication of their material.
Editors and publishers waiver of responsibil-
ity. Statements and opinions expressed in articles and
communications herein are those of the author(s)
and not necessarily those of the Editors and pub-
lisher. The Editors and publisher disclaim any respon-
sibility or liability for such material. Neither the Edi-
tors nor the publisher guarantee, warrant, or endorse
any product or service advertised in the Journal, and
they do not warrant any claim made by the manufac-
turer of such product or service.
Institutional Review. Manuscripts that involve
research conducted on human subjects must follow
the principles outlined in the Declaration of Helsinki
(http://www.wma.net/e/policy/pdf/17c.pdf) and
include a statement in the Methods section that the
experimental protocol and informed consent were
approved by the Institutional Review Board and that
all subjects gave informed consent. Manuscripts that
report animal experiments must include a statement
in the Methods section that the study was approved
by the Institutional Review Board and that the animal
care complied with the Guide for the Care and Use of
Laboratory Animals, Institute of Laboratory Animal
Resources, Commission on Life Sciences, National
Research Council. Washington: National Academy
Press, 1996 (http://stills.nap.edu/readingroom/
books/labrats/)
Clinical Trial Registration. In 2004, the Inter-
national Committee of Medical Journal Editors (IC-
MJE) recommended that clinical trials be registered
in a public database as a prerequisite for subsequent
publication (De Angelis C, Drazen JM, Frizelle FA,
et al. Clinical trial registration: a statement from the
International Committee ofMedical Journal Editors.N
Engl J Med 2004;351:1250-1). Effective July 1, 2007
the Journal of Vascular Surgery® will adopt the policies
recommended by the ICMJE and require the pre-
registration of all prospective clinical trials that have a
control group (Cronenwett J, Seeger J. Requirement
for Registration of Clinical Trials. J Vasc Surg 2007;45:
1). In addition, the Journal will also require the pre-
registration ofany commercially sponsored clinical trial,
including Phase I and II trials. We do not anticipate
registration of retrospective reviews or summaries of
standard clinical treatment. Clinical trials that meet the
above requirement and commence after July 1, 2007
must be registered prior to enrollment of the first pa-
tient. Relevant trials that began before this datemust be
registered prior to editorial review.Registrationmust be
indicated by providing the unique study number as-
signed at www.clinicaltrials.gov, the principle site of
registration sponsored by the National Library of Med-
icine (NLM). Detailed directions and a tutorial for regis-
tering a trial are available at http://prsinfo.clinicaltrials.
gov. Authors of unregistered trials or those with inade-
quate information in the registrywill be given anopportu-
nity to convince the Editors that their rationale for omit-
ting this was critical, but it is the Journal’s expectation that
clincal trials involvingprospectivecomparisonof treatment
or any that are commercially sponsored will all be regis-
tered after July 1, 2007.
SUBMISSION OF ORIGINAL MANUSCRIPT
The Journal’s requirements for submission of a
manuscript are in accordance with “Uniform Re-
quirements forManuscripts Submitted to Biomedical
Journals: Writing and Editing for Biomedical Publi-
cation” of the International Committee of Medical
Journal Editors (ICMJE), published in JAMA 1997;
227:927-34 and available at http://www.icmje.org/
JOURNAL OF VASCULAR SURGERY/July 2011 19A
index.html. This article is not covered by copyright
and can be reproduced and distributed if such use is
not for profit. The instructions for authors are sum-
marized below.
General requirements
Length. The length of clinical and basic research
studymanuscripts, including abstract (maximum 400
words), text (average 3200 words and maximum
3500 words), tables (one per page), copies of each
figure (one per page), figure legends, and reference
list, should not exceed 25 typewritten double-spaced
pages with a 12-point font and 1-inch margins. Note
that authors can include additional data (eg, details of
methods, statistical analysis, tables, discussions) as
appendices that will be published on the Journal’s
Web site but not in the print version. Manuscripts
that do not meet these guidelines will be sent back to
the authors for editing before review.
Submission of manuscripts
Manuscripts should be submitted to the Journal of
Vascular Surgery® electronically, using the Web-based
system Editorial Manager. To submit a manuscript,
authors should login to the Web site http://jvs.
editorialmanager.com, where detailed instructions
can be found. Manuscripts, including figures and ta-
bles, are submitted via thisWeb site inmultiple files. To
use this system authors must have an Internet connec-
tion, an e-mail program, a Web browser, a word pro-
cessor, and Adobe Acrobat Reader (which can be
downloaded at no charge at the above Web site).
Formatting instructions.Manuscripts are prefer-
ably created in a PC or Macintosh word processor
(eg, Microsoft Word or Corel WordPerfect). Manu-
scripts created in such a manner can be imported
directly into Editorial Manager.
• Double-space all sections (ie, abstract, text, ac-
knowledgments, references, figure legends, and
tables).
• Use at least 1-inch margins on all sides.
• Use at least 12-point type (not smaller).
• Number the pages consecutively in the upper
right corner.
Basic information for electronic submission.
To upload a manuscript using Editorial Manager,
authors must provide the following information:
• a concise, informative, declarative title of the
manuscript;
• DO NOT format the title as a question;
• DO NOT include a colon in the title or make
it two parts using any other punctuation;
• DO NOT restate the article type (ie, Case
report, Review, etc);
• DO NOT state the type of statistical analysis
used, i.e. multivariate analysis;
• DO NOT include your Institution Name in
the title;
• the preferred name(s), initials, and surname of
the author(s) and their highest earned academic
degrees, listed in the order that these should
appear if the manuscript is published;
• departmental and institutional affiliations of
each author;
• a completed Author Role, Originality, and
Competition of Interest form, including all fi-
nancial or material support provided to the au-
thors;
• the meeting, date, and place where the paper
was presented, if applicable;
• the name and address of the person to whom
correspondence is to be addressed;
• the name and address of the author to whom
requests for reprints should be addressed (if
reprints will be available).
Forms to be transmitted with submitted man-
uscripts. All manuscripts must be accompanied by a
completed Author Role, Originality, and Competi-
tion of Interest form. This information will be pro-
vided to reviewers and Editors for their evaluation of
appropriate involvement. A competition of interest
statement will be published with each manuscript
based on the information provided on this form.
Authors are referred to a detailed publication on this
topic (Johnston KW, Rutherford RB. Disclosure of
competition of interest. J Vasc Surg 1999;30:200-2).
If an author fails to disclose his/her competitive
interests, the actions open to the Editors are de-
scribed in Johnston KW, Rutherford RB. Failure to
disclose competitive interests. J Vasc Surg 2000;31:
1306. Beginning July 1, 2007, this form will also
request information on the unique study number
assigned at www.clinicaltrials.gov if your study meets
our requirements for registration (see the Clinical
Trial Registration section above). In addition, all new
manuscripts must be accompanied by a Reviewer
Request form, submitted using Editorial Manager.
The form requires the names and addresses of three
potential reviewers with whom there is no conflict of
interest, ie, a suggested reviewer should not be a close
personal friend, an individual from the same institu-
tion, or an individual with whom any of the authors
has collaborated. Because reviewers are asked to de-
cline to review any application with which they may
have a conflict of interest, suggesting suitable expert
reviewers will minimize delays. The authors may also
include the names of individuals who would not be
suitable reviewers because of potential professional or
personal conflicts of interest. Finally, all revised man-
uscripts must be accompanied by a Review Response
form and an Author Contribution Statement form.
All of these forms are available for downloading from
the Editorial Manager Welcome page (http://
jvs.editorialmanmager.com).
Material to be submitted after manuscript ac-
ceptance.
The Copyright Transfer form is now being col-
lected by the publisher. After a manuscript is
accepted, the publisher will contact the corre-
sponding author and send out a form to sign.
For further assistance and clarification, please
contact:
Jessica Brabant - Managing Editor
jbrabant@vascularsociety.org
Phone: 312-334-2317
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Consent to reproduce data. It is the authors’
responsibility to obtain written consent from the
copyright owner and the original author to reproduce
direct quotations, tables, or illustrations that have
appeared in copyrighted material and to provide
complete information regarding their source. Simi-
larly, permission must be obtained for tables and
figures that have been modified from other publica-
tions. Such permissions must accompany the Copy-
right Transfer form at the time of acceptance.
Patient consent. Photographs of identifiable per-
sons must be accompanied by signed releases from
patients or from both living parents or guardians of
minors. Similarly, consent must be obtained if a per-
son can be identified from the case description. Such
releases must accompany the Copyright Transfer
form at the time of acceptance.
Description of manuscript components
Title. Titles must be concise and accurately reflect
the content of the manuscript. Furthermore, titles
should be declarative, stating the topic and results when
possible, rather than posing a question. This is impor-
tant for assisting clinicians and researchers find the
article in Medline once it has been published.
Authors. By submitting this manuscript, each au-
thor certifies that they have made a direct and sub-
stantial contribution to the work reported in the
manuscript by participating in each of the following
three areas: (1) conceiving and designing the study;
or collecting the data; or analyzing and interpreting
the data; (2) writing the manuscript or providing
critical revisions that are important for the intellectual
content; and (3) approving the final version of the
manuscript. They have participated to a sufficient
degree to take public responsibility for the work
and believe that the manuscript describes truthful
facts. They declare that they shall produce the data
on which the manuscript is based for examination
by the editors or their assignees, should it be
requested. Each author also agrees to allow the
corresponding author to make decisions regarding
submission of the manuscript to the Journal,
changes to galley proofs, and prepublication re-
lease of information in the manuscript to the me-
dia, federal agencies, or both.
Generally, eight is the maximum number of ex-
pected authors for a clinical or basic research manu-
script, and six for a case report or technical note. The
Editors request that additional authors be carefully ex-
amined with respect to the authorship criteria listed
above and suggest that some might better be acknowl-
edged than listed as authors. Further, the Editors re-
quest that authors beyond this expected number be
specifically justified in the details section of the elec-
tronic submission. In special circumstances (eg, multi-
center trials), the editors will consider as many as eight
authors for clinical or basic research papers, and six for
case reports and technical notes, but this is the absolute
maximum. As an alternative, a smaller number of key
authors can submit the work on behalf of a larger
research group, which can then be listed and acknowl-
edged in an appendix. If an author has collaborated in a
project but does not meet all the requirements for
authorship, he or she should be recognized in the
acknowledgment section of the manuscript.
For more information on the requirements for
authorship, see the “Uniform Requirements for
Manuscripts Submitted to Biomedical Journals:
Writing and Editing for Biomedical Publication”
(http://www.icmje.org/index.html), section II.A
on Authorship and Contributorship. Beginning in
January 2005, the Journal began publishing an Author
Contribution Statement at the end of each clinical and
basic research manuscript. This information for this
statement should first be submitted as part of the Au-
thor Role form upon submission, and attested to by a
completed Author Contribution Statement form at the
time of acceptance. For further information, please see
“Criteria for Authorship” J Vasc Surg 2005;42:599.
Abstract. A structured abstract is required for all
manuscripts except case reports, technical notes
(both of which require a shorter, nonstructured ab-
stract), vascular images, special articles, editorials,
and presidential addresses. The abstract must be up-
loaded as a separate file from the rest of the manu-
script, using EditorialManager, andmust include the
title of the manuscript, the names of the authors,
affiliations, and contact information for the corre-
sponding author. The abstract replaces the summary
and ordinarily should clearly state, in approximately
250 words (but never more than 400 words), the
main factual points of the article. The abstract should
be informative, not descriptive.Detailed results should
be included in the abstract, since many readers only
have access to abstracts and not the entire article. A
structured abstract will include combinations of the
following headings that apply and are informative, as
described in detail in previous publications (Haynes
RB, Mulrow CD, Huth EJ, Altman DG, Gardiner
MJ. More informative abstracts revisited. Ann Intern
Med 1990;113:69-76. Ad Hoc Working Group For
Critical Appraisal of the Medical Literature. A pro-
posal for more informative abstracts of clinical arti-
cles. Ann Intern Med 1987;106:598-604):
• Objective: a precise statement of the exact ques-
tion(s) addressed by the article and, if appropri-
ate, the hypothesis
• Design of study: the basic design
• Setting: community or referral center, institu-
tional or private practice, ambulatory or hospi-
talized patients
• Subjects: eligibility criteria, selection method,
total number, proportion withdrawn
• Interventions: the exact treatment or interven-
tions
• Main outcome measure(s): the method of as-
sessing subjects
• Results: the main results should be stated with
statistical significance
• Conclusions: only conclusions supported by the
study and their clinical application should be
stated.
For brevity, phrases rather than complete sentences
can be used in some sections. Tables, figures, reference
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citations, and trademarked names should not appear in
the abstract. Since many readers only have access to the
abstract, it is essential that it contain numerical results
and not simply summary conclusions.
Clinical Relevance. For Basic Research Studies,
the Journal includes a paragraph describing the clin-
ical relevance of all published basic research articles.
This will be printed immediately below the Conclu-
sion section of the abstract of the article, but will not
be included in the Abstract available onMedline. The
purpose of this section is to interest clinical surgeons
in reading this work and help them understand its
significance. Basic Research authors must submit a
paragraph of approximately 100 words entitled
“Clinical Relevance” in which they relate the basic
research study they are reporting to its current or
future clinical applications.
Text. Manuscripts must conform to standard
English usage and are subject to editing in confor-
mance with the policies of the Journal. For reference,
authors may consult the American Medical Associa-
tion’s Manual of Style (Iverson C, Flanagin A, Fon-
tanarosa PB, et al. 9th ed. Baltimore: Williams &
Wilkins, 1998). The following changes have been
made from the 8th edition of the American Medical
Association’s Manual of Style:
• Abbreviations no longer include periods (ie, Dr,
eg, US, Jr, St, Rd).
• A capital P is now used for probability, and no
zero is used before the decimal when the figure
cannot exceed 1 (P  .007).
• The new style uses new abbreviations for some
units of measure (L, liter; in, inch; ft, foot; yd,
yard; mol, mole; mol/L, molar).
• Units of time in virgule constructions or tables
are now abbreviated (ms, millisecond; s, second;
min, minute; h, hour; d, day; wk, week; mo,
month; y, year;).
• Units that are used as adjectives are now hy-
phenated (8-mL container, 10-cm visual analog
scale).
Manuscript body. The manuscript, including the
abstract, must be uploaded as a separate file using
Editorial Manager. The usual sections for a manu-
script include Introduction, Methods, Results, and
Discussion. Subheadings may be useful and help clar-
ify the content in longer papers. Methods must be
described in sufficient detail to allow others to repro-
duce the work. For established methods, appropriate
references and a brief description are sufficient; but
for new methods, appropriate details are required. If
the description of the method is very long, the tech-
niques should be summarized and referenced and the
details provided as an appendix that will be published
on the Web but not in print.
For human studies, the following details are gen-
erally important: eligibility (inclusion and exclusion
criteria), randomization method, blinding methods,
total consecutive patients enrolled, and number of
exclusions or drop-outs and reasons.
For randomized controlled trials, the CONSORT
document provides reporting guidelines that should
bemet in articles submitted to the Journal (Moher D,
Schultz ICF, Altman DG for the CONSORT group.
The CONSORT statement: revised recommendation
improving the quality of reports of parallel-group
randomised trials. Lancet 2001;357:1191-4). Full
details are available at http://www.consort-state-
ment.org/. This article provides a checklist of the
items that should be included in the report of the
methods, results, and discussion and the suggested
details of a flow diagram that gives information on
patient flow through the study. Observational studies
should include these details as well.
Reporting standards have been published that pro-
vide guidelines for reporting meta-analyses of the
randomized controlled studies (Moher D, Cook DJ,
Eastwood S, Olkin I, Rennie D, Stroup DF. Improv-
ing the quality of reports of meta-analyses of random-
ized controlled trials: the QUORUM statement. Lan-
cet 1999;354:1896-900) and observational studies
(StroupDF,Berlin JA,Morton SC,Olkin I,Williamson
GD, Rennie D, et al. Meta-analysis of observational
studies in epidemiology: a proposal for reporting.Meta-
analysis of Observational Studies in Epidemiology
(MOOSE) group. JAMA 2000;283:2008-12).
Manuscripts involving research conducted on hu-
man subjects and/or that report animal experiments
must follow all requirements listed in the Institu-
tional Review section above. Details of the statistical
methods should be referenced and, if uncommon,
the principles explained. If a manuscript is considered
acceptable for publication, the Editors may choose to
subject it to formal statistical review to ensure that the
study population was clearly defined, that the design
of the study was suitable, that appropriate statistical
methods were used, and that the subsequent conclu-
sions were supported.
Generic drug names should be used, specifically the
United States Adopted Name (USAN). Proprietary
drug namesmay be cited in parentheses. Generic equip-
ment names should be used whenever possible and the
proprietary nameof the equipment cited in parentheses;
after the proprietary name, cite the manufacturer and
the city, state, and country of manufacture.
Measurements (height, weight, etc,) should be
stated in metric units. Hematologic and clinical
chemistry measurements can be stated in System
International (SI) units or non-SI units. Note that SI
units are recommended in the “Uniform Require-
ments for Manuscripts Submitted to Biomedical
Journals: Writing and Editing for Biomedical Publi-
cation” (http://www.icmje.org/index.html).
Only standard abbreviations should be used; avoid
unusual or coined abbreviations. The first time any
abbreviation is used it should be included in paren-
theses after the words it replaces. Abbreviations
should not be used in the title or abstract. Manuscripts
should conform to the guidelines for reporting on vas-
cular surgery. The following have been developed by
the Ad Hoc Committee on Reporting Standards and
accepted by the Society for Vascular Surgery®:
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• Venous severity scoring: An adjunct to venous
outcome assessment. J Vasc Surg 2000;31:
1307-12.
• Recommended standards for reports dealing
with lower extremity ischemia: Revised version.
J Vasc Surg 1997;26:517-38.
• Reporting standards in venous disease. J Vasc
Surg 1988;8:172-81.
• Reporting standards in venous disease: an up-
date. J Vasc Surg 1995;21:635-45.
• Suggested standards for reports dealing with
cerebrovascular disease. J Vasc Surg 1988;8:
721-9.
• Suggested standards for reporting on arterial
aneurysms. J Vasc Surg 1991;13:452-8.
• Standards in noninvasive cerebrovascular test-
ing. J Vasc Surg 1992;15:495-503.
• Reporting standards for lower extremity arterial
endovascular procedures. J Vasc Surg 1993;17:
1103-7.
• Recommended standards for reports dealing
with arteriovenous hemodialysis accesses. J Vasc
Surg 2002;35:603-10.
• Reporting standards for endovascular aortic an-
eurysm repair. J Vasc Surg. 2002;35:1048-60.
• Identifying and grading factors that modify the
outcome of endovascular aortic aneurysm re-
pair. J Vasc Surg. 2002;35:1061-6.
Acknowledgments. Acknowledgments should
include collaborators, if they give written permission
to be acknowledged, and technical and secretarial
assistance, as appropriate.
References. Cite references selectively (using no
more than 40); an extensive literature review is rarely
necessary, and only pertinent references should be given
(ie, those that provide the basis for a key statement).
References should be cited consecutively in the text by
superscript Arabic numbers in the order in which they
are first mentioned in the text, a table, or a figure.
References should not be cited alphabetically. The ref-
erence list should be typed double-spaced. References
to articles in press must include authors’ names, title of
article, and name of journal. Personal communications
and unpublished data are not to be cited as references;
instead, indicate these sources in the text at the appro-
priate place and include the individual’s preferred given
name, initials, surname, title, city, and year of commu-
nication. Append to the manuscript a note of approval
from the source for the statement. Make sure all refer-
ences have been verified. The accuracy of the references,
including spelling of references in foreign languages, is
the responsibility of the authors and is crucial so that
they can be linked to the original citation in the Web
version. Abbreviate journal names according to the
Index Medicus. Authors should be certain that all refer-
ences use the standard abbreviated journal names ac-
cording to the Index Medicus. This is imperative to
ensure linking of references in the online version of the
Journal. References that do not use the standard abbre-
viated journal names will not link. If there are six or
fewer authors, list all; if seven or more, list only the first
six, then et al. The format for references is described in
detail in “Uniform Requirements for Manuscripts
Submitted to Biomedical Journals: Writing and Ed-
iting for Biomedical Publication” (http://www.
icmje.org/index.html). Examples follow:
Format for journal articles: Josa M, Khuri SF,
Braunwald NS, VanCisin MF, Spencer MP, Evans DA,
et al. Delayed sternal closure: an improved method of
dealing with complications after cardiopulmonary by-
pass. J Thorac Cardiovasc Surg 1986;91:598-603.
Format for books: Berger HJ, Zaret BL, Cohen LS.
Cardiovascular nuclear medicine. In: Goldberger E,
editor. Textbook of clinical cardiology. 1st ed. St
Louis: CV Mosby; 1982. p. 326-45.
Tables. Tables should supplement, not duplicate,
the text. Number them consecutively in Roman nu-
merals according to their order of citation in the text.
Because tables should be self-explanatory, provide a
brief caption for each table. Each table should be
double-spaced and uploaded to Editorial Manager as
a separate file. Abbreviations used in the table should
be explained in a footnote; however, abbreviations
that have been defined in the body of the text do not
need to be spelled out or explained in the table. If a
table or any data therein have been previously pub-
lished, a footnote in the table must give full credit to
the original source, and the original publisher’s per-
mission to reproduce the table must be provided.
Editorial Manager now includes an Artwork
Quality Checking tool. Artwork Quality Results are
either Pass, Pass with Warning, or Fail. If the result is
Pass, no further action must be taken. If the result is
Pass with Warning or Fail, please address the changes
listed and upload a new file that receives a Pass result.
If you are unable to obtain a pass result, check the
artwork quality results and review your image’s qual-
ity at 18 pica (or three inches wide). This number can
be found in the upper right hand corner of the
artwork quality check results box. If your figure is 300
DPI or greater at 18 pica, you may submit your
manuscript files regardless of the pass/fail result. If it
is lower than 300, youmust improve the resolution of
your figures before submitting your manuscript. Do
not send original artwork, x-ray films, etc to the
editorial office. All figures must be of suitable quality
for publishing—300 dpi for color or black and white
photos and 1200 dpi for line drawings. Number
figures consecutively in Arabic numerals in the order
in which they appear in the text.
Illustrations. Limit illustrations to those that am-
plify, not duplicate, the text. A reasonable number of
line or halftone illustrations will be reproduced. In-
clusion of color illustrations is at the discretion of the
Editor. Original drawings or graphs should be pre-
pared by computer methods or by a professional
artist. All images must be provided electronically, and
uploaded via the Editorial Manager system as sepa-
rate files and are preferred in either TIFF or EPS
format. Images should be sized with either a 3-inch
width (for 1 column format) or 6.5-inch width (for 2
column format). All image files must be at 300 dpi.
Detailed artwork instructions and help with format-
ting, sizing, scanning, and file naming can be found at
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the Elsevier Author Gateway at http://authors.
elsevier.com/. The Artwork Quality Results will also
display specific information on any problems with the
file as well as possible solutions. This means that the
Author can make any necessary changes to the art-
work files and upload new files, better suited for
production.
In life table graphs, lines should be truncated when
the standard error exceeds 10%. Furthermore, the num-
ber of patients should be shown below the graph at
appropriate time points. Since life table graphs are pre-
ferred for in-text inclusion, data tables should be sub-
mitted only for the online version of the manuscript if
the authors desire to provide this level of detail.
Operative and pathology photographs should be
in color. Other figures and charts should be black and
white unless sufficiently complex to require color.
Figure legends. Type legends double-spaced in
one separate Word file. Indicate original magnification
and stain for photomicrographs. If a figure has been
previously published, the legendmust give full credit to
the original source and a letter from the original source
giving permission to reproduce the figure must be sub-
mitted.
Video clips. Video clips accompanying a manu-
script must be limited to no more than one minute in
length and no more than 5 MB in file size. If ac-
cepted, they will be published on the Journal Web
site. Videos must be formatted as either a QuickTime
or MPEG file and can be uploaded in Editorial Man-
ager just like any other manuscript file, and e-mailed
to the editorial office. Authors who want their videos
accessible in a streaming format must also provide
either a single SureStream file or three uniquely
named single-rate clips (28.8, 56, T1) with an SMIL
file to list the bandwidth choices. Video clips must
meet production quality standards to be published on
the Web without modifications or editing by the edito-
rial office. The Journal can accept only video submis-
sions that meet the Journal’s formatting and image
quality requirements. Authors will be notified if there
are any problems with submitted files and asked to
resubmit modified files. Image editing and correct
formatting are the author’s responsibility. Video clips
accepted for publication will be posted to the Jour-
nal’s Web site in both non-streaming format such as
QuickTime andMPEG for optimal image quality and
in a streaming video format for those who prefer
faster downloading.
Statistical analysis. In reports that contain statisti-
cally analyzed data, the corresponding author must
identify, in the Author Role form, the coauthor or
consultantwhowas responsible for the statistical analysis.
SUBMISSION OF OTHER TYPES OF
PAPERS
Manuscripts that do not meet these guidelines will
be sent back to the authors for editing before review.
All manuscripts must be submitted through Editorial
Manager at http://jvs.editorialmanager.com, using
the appropriate article type.
Vascular and endovascular techniques. A descrip-
tion of new techniquewill be considered for publication
but should not exceed 1200words, four figures, and 10
references, with an overall limit of 12 typewritten dou-
ble-spaced pages with 12-point font and 1-inch mar-
gins. A brief 100-word nonstructured abstract, up-
loaded as a separate file into Editorial Manager, should
emphasize the importance of the new development.
Authors submitting technical notes must also submit a
completed Author Role, Originality, and Competition
of Interest form. A Copyright Transfer form must be
submitted to the publisher’s office for accepted Vas-
cular and Endovascular Techniques. Vascular and
Endovascular Techniques should focus on the details
of a new procedure or technique, and contain figures
or line drawings that illustrate these new procedures.
There may be a brief case report as well, but the
purpose of the manuscript is to describe the tech-
nique or procedure. The discussion should indicate
the basis for the author’s conclusion that this tech-
nique is effective, and potentially compare the out-
comes, advantages, and disadvantages of this new
technique to what is currently done.
Case reports. A case report will be considered for
publication only if it describes a new disease, important
original observations, or a unique technical approach
and succinctly reviews the relevant literature. Case re-
ports should not exceed 1200 words, three figures, and
20 references, with an overall limit of 12 typewritten
double-spaced pages with 12-pointfont and 1-inch
margins. A brief 100-word nonstructured abstract, up-
loaded as a separate file, should emphasize the impor-
tant message illustrated by the case(s). Authors submit-
ting case reports must also submit a completed Author
Role, Originality, and Competition of Interest form. A
Copyright Transfer form must be submitted to the
publisher’s office for accepted case reports.
Clinical update. Articles in this section are in-
tended to be concise, current reviews of clinical topics
that will impact patient care. Interested authors
should contact the Editors to determine if a particular
topic would be of interest and is not already under
review. Articles should be no longer than 3000
words, should have a limited, but useful reference list,
and comprise no more than 15 typewritten double-
spaced pages with 12-point font and 1-inch margins,
including tables. A brief 150-word nonstructured
abstract, uploaded as a separate file, should empha-
size the importance of the clinical update. The files
should be submitted using the Editorial Manager
system under the article type “Clinical Update.”
Clinical Updates should provide short, relevant clin-
ical reviews on important topics regarding vascular
disease. Authors submitting clinical updates must
also submit a completed Author Role, Originality,
and Competition of Interest form. A Copyright
Transfer form must be submitted to the publisher’s
office for accepted clinical updates.
Editorials. The Editors may solicit an editorial on
an important manuscript or topic related to vascular
surgery to emphasize or explain the significance and
relevance of the work to a general vascular surgery
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audience or to present different views to assist the
readers in making a decision on the application of the
results and conclusions. The work should be objec-
tive and authoritative and should not exceed 1200
words in length. Even though editorials are solicited,
there is no prior commitment to publish them. Au-
thors of editorials must also submit a completed
Author Role, Originality, and Competition of Inter-
est form. A Copyright Transfer formmust be submit-
ted to the publisher’s office for accepted editorials.
Letters to the Editor. A letter up to 500 words in
length with six references or less and one illustration
or table will be considered for publication if it ampli-
fies a recent article in the Journal by extending or
clarifying the original manuscript or by presenting an
opposing interpretation of the results or conclusions.
Letters may also be used to submit brief original
observations or opinions. Authors submitting letters
must also submit a completed Author Role, Original-
ity, and Competition of Interest form. A Copyright
Transfer form must be submitted to the publisher’s
office for accepted letters before publication. The
authors of the original paper will be provided with an
opportunity to respond to a letter to the Editor. If the
authors respond in a timely fashion, both the letter to
the Editor and the authors’ response will be pub-
lished together. Letters accepted for publication may
be copyedited.
Presidential addresses. The Presidential Address
from a meeting of the Society of Vascular Surgery®
and affiliated societies will be published after copy-
editing and optional review, which may provide sug-
gested improvements. Authors submitting presiden-
tial addresses must also submit a completed Author
Role, Originality, and Competition of Interest form.
A Copyright Transfer form must be submitted to the
publisher’s office for accepted presidential addresses.
Vascular images.This section presents interesting
vascular images and associated short educational
summaries in a focused, case-report format. Previ-
ously published images will not be considered for this
section. When submitting this type of manuscript,
please make sure that you have designated which
image should appear on the Journal cover. The Edi-
tor may choose to use a different image if your
manuscript is selected, however it is required that you
designate one image as the cover image before sub-
mission. Color illustrations that are suitable for the
Journal cover are preferred. Cover images must not
include arrows or any other added graphics, and
whenever possible, text should be cropped out of the
cover image. Appropriate images include radio-
graphs, pathology, anatomy, operative findings, and
other relevant clinical pictures. The images should
illustrate features of vascular disease, including tech-
nical approaches. Illustrations and text must be con-
fined to one printed page (no more than 350 words,
with a limit of four illustrations: one for the cover and
three that must fit in the right hand column), and
images for the cover should possess both scientific
and artistic merit. Descriptions of images must be
included in the text, and only key references should
be provided (with a limit of two). Images must be of
professional quality and should be initially provided
electronically by uploading (with the rest of the man-
uscript) using the Editorial ManagerWeb based sub-
mission system at http://jvs.editorialmanager.com.
Detailed artwork instructions and help with format-
ting, sizing, scanning, and file naming can be found at
the Elsevier Author Gateway at http://authors.
elsevier.com/. Authors submitting vascular images
must also submit a completed Author Role, Original-
ity, and Competition of Interest form. A Copyright
Transfer form must be submitted to the publisher’s
office for accepted vascular images. Given the short
length of these articles, a maximum of four authors
are permitted.
Invited “Special Section” submissions. Al-
though manuscripts for these “special sections” will
generally be solicited from specific authors, unsolic-
ited submissions could be considered. Authors of
unsolicited manuscripts should contact the Journal
office to discuss their potential topic with the Edito-
rial Office prior to submission.
Review articles. Review articles may be solicited
by the Editors directly or in response to suggestions
by prospective authors and will be evaluated as inde-
pendent submissions without prior correspondence.
They will be subject to peer review. These reviews are
comprehensive with full reference lists, as opposed to
Clinical Updates which are more focused, as de-
scribed above. Review articles include a 250-400
word abstract, 3500-5000 word body, and typically
no more than 40 references.
Practice management. Manuscripts for the prac-
tice management section will be invited papers focus-
ing primarily on issues of interest to the practicing
specialist, including office management issues, vascu-
lar laboratory management, sociopolitical topics, re-
cruitment, and reimbursement issues. Topics will be
of interest to both academic and nonacademic prac-
titioners. This article type must include a 150 word
abstract and the body of the paper should be no
longer than 1500 words.
Clinical trials update. Manuscripts for the “clin-
ical trials update section will be invited papers from
the Principal Investigators of ongoing clinical trials.
The goal of this section is to update the readers on the
status of these trials and to communicate the status of
clinical investigations in a timely fashion. These man-
uscripts are brief, no more than 1000 words exclud-
ing a 150-200 word abstract. If you are interested in
contributing to this section, please contact the edito-
rial office.
Evidence summary. Articles in this section will
summarize the available evidence on a topical issue in
clinical practice of vascular surgery and endovascular
therapy. It will be a brief (1-3 pages) presentation of
the published evidence, often in tabular form, relat-
ing to the subject. The goal of this section is to give
the readers a ready wealth of evidenced information
about a specific topic, which would positively and
immediately influence their day to day practice.
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Historical vignettes in vascular surgery.Manu-
scripts for the historical vignette section will be in-
vited papers as well as free submissions from authors
with an interest in Historical Vascular Heritage. The
goal of this section is to remind and/or teach the
readers about physicians and surgeons who have con-
tributed previously. Also, other topics to include
organizational efforts and procedures are to be con-
sidered. Manuscripts of a maximum of 2500 words
with approximately 3 figures, 10-15 references and
no more than 3 authors are ideal.
Other. This category encompasses all other forms
of papers that are published by the Journal. These
papers are also submitted through Editorial Manager
at http://jvs.editorialmanager.com. Common ex-
amples include:
• Position statements and practice guidelines.
Position papers and practice guidelines devel-
oped under the auspices of the Society for Vas-
cular Surgery® will be published after approval
by the Board of Directors of the Society.
• Review articles. Review articles may be solic-
ited by the Editors directly or in response to
suggestions by prospective authors, and will be
evaluated as independent submissions without
prior correspondence. They will be subject to
peer review. These reviews are comprehensive
with full reference lists, as opposed to Clinical
Updates, which are more focused, as described
above.
• Obituaries. The Journal will publish obituaries
on individuals who have been on the Council of
the Society for Vascular Surgery®, or the Edito-
rial Board of the Journal and have made signif-
icant contributions to the art and science of
vascular surgery. At the discretion of the Edi-
tors, obituaries may be published for other in-
dividuals who have made exemplary contribu-
tions.
Reprints
Individual reprints of articles may be requested
from the author. The corresponding author will re-
ceive a price schedule and order form for reprints
shortly before the time of publication.
Submission Length Limitations
Max
Authors
Abstract
Max Words
Body
Max Words Figures Tables
References- 6 (not 3)
authors et al
Clinical 8 250-400 3200-3500 1 per page 1 per page 40
Basic Science 8 250-400 3200-3500 1 per page 1 per page 40
Review 8 250-400 3500-5000 1 per page 1 per page 40
Clinical Update 6 100-150 3000 1 per page 1 per page 40
Clinical Trial Update 6 150-200 1000 1 per page 1 per page 20
Case Report 6 100 1200 3 0 20
Practice Management 6 150-200 3000 1 per page 1 per page 30
Evidence Summary 6 150 1500 FigTab  5 FigTab  5 30
Vascular Image 4 NA 350 4 0 3
Historical Vignette 3 NA 2500 3 3 15
Letter to Editor 6 NA 500 1 1 6
Vascular Techniques 6 100-150 1200 1 per page 1 per page 10
The Information for Authors can also be found online at https://
www.editorialmanager.com/jvs/account/AuthorInstructions.pdf.
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